accepted manuscript

More documents

Recommendations

Info

ACCEPTED MANUSCRIPT Mitochondrial dysfunction in Parkinson's disease Konstanze F. Winkhofer* and Christian Haass German Center for Neurodegenerative Diseases (DZNE) Munich and Adolf Butenandt Institute, Biochemistry, Ludwig Maximilians University, 80336 Munich, Germany *To whom correspondence should be addressed: Konstanze F. Winklhofer, Schillerstr. 44, D-80336 Munich, telephone: +49 89 2180 75483, fax: +49 89 2180 75415, E-mail: Konstanze.Winklhofer@med.uni- muenchen.de ACCEPTED MANUSCRIPT Key words: Parkinson's disease, mitochondria, parkin, PINK1, a-synuclein, DJ-1, LRRK2 1
Abstract ACCEPTED MANUSCRIPT Mitochondria are highly dynamic organelles which fulfill a plethora of functions. In addition to their prominent role in energy metabolism, mitochondria are intimately involved in various key cellular processes, such as the regulation of calcium homeostasis, stress response and cell death pathways. Thus, it is not surprising that an impairment of mitochondrial function results in cellular damage and is linked to aging and neurodegeneration. Many lines of evidence suggest that mitochondrial dysfunction plays a central role in the pathogenesis of Parkinson's disease (PD), starting in the early 1980s with the observation that an inhibitor of complex I of the electron transport chain can induce parkinsonism. Remarkably, recent research indicated that several PD-associated genes interface with pathways regulating mitochondrial function, morphology, and dynamics. In fact, sporadic and familial PD seem to converge at the level of mitochondrial integrity. ACCEPTED MANUSCRIPT 2
Page 1: ÔØ ÅÒÙ× ÖÔØ Mitochondrial
Page 5 and 6: ACCEPTED MANUSCRIPT function mechan
Page 7 and 8: ACCEPTED MANUSCRIPT high lipophilic
Page 9 and 10: ACCEPTED MANUSCRIPT transfer from N
Page 11 and 12: ACCEPTED MANUSCRIPT force (ΔpH and
Page 13 and 14: ACCEPTED MANUSCRIPT about 1500 diff
Page 15 and 16: ACCEPTED MANUSCRIPT mtDNA point mut
Page 17 and 18: ACCEPTED MANUSCRIPT increases the v
Page 19 and 20: 2.1.2. PINK1 substrates ACCEPTED MA
Page 21 and 22: 2.2. Parkin ACCEPTED MANUSCRIPT 2.2
Page 23 and 24: ACCEPTED MANUSCRIPT Remarkably, LaV
Page 25 and 26: ACCEPTED MANUSCRIPT [204]. None of
Page 27 and 28: ACCEPTED MANUSCRIPT 218] (see Fig.
Page 29 and 30: ACCEPTED MANUSCRIPT strategies migh
Page 31 and 32: ACCEPTED MANUSCRIPT autophagy in PI
Page 33 and 34: 2.3. DJ-1 ACCEPTED MANUSCRIPT Mutat
Page 35 and 36: ACCEPTED MANUSCRIPT Similarly to ot
Page 37 and 38: ACCEPTED MANUSCRIPT 2527 amino acid
Page 39 and 40: Acknowledgements ACCEPTED MANUSCRIP
Page 41 and 42: References ACCEPTED MANUSCRIPT [1]
Page 43 and 44: ACCEPTED MANUSCRIPT Sciences of the
Page 45 and 46: ACCEPTED MANUSCRIPT biological chem
Page 47 and 48: ACCEPTED MANUSCRIPT [47] B. Janetzk
Page 49 and 50: 486-517. ACCEPTED MANUSCRIPT [63] B
Page 51 and 52: ACCEPTED MANUSCRIPT Parkinson's dis
Page 53 and 54:
ACCEPTED MANUSCRIPT variants in idi
Page 55 and 56:
ACCEPTED MANUSCRIPT causes of Parki
Page 57 and 58:
ACCEPTED MANUSCRIPT [125] A. Grunew
Page 59 and 60:
ACCEPTED MANUSCRIPT [136] G.B. John
Page 61 and 62:
ACCEPTED MANUSCRIPT maturation or s
Page 63 and 64:
ACCEPTED MANUSCRIPT [163] C. Hampe,
Page 65 and 66:
114-122. ACCEPTED MANUSCRIPT [179]
Page 67 and 68:
ACCEPTED MANUSCRIPT (2004) 1328-133
Page 69 and 70:
ACCEPTED MANUSCRIPT Dalkara, N. Oze
Page 71 and 72:
ACCEPTED MANUSCRIPT [217] H. Deng,
Page 73 and 74:
ACCEPTED MANUSCRIPT dispensable for
Page 75 and 76:
35 (2001) 301-310. ACCEPTED MANUSCR
Page 77 and 78:
ACCEPTED MANUSCRIPT multiplications
Page 79 and 80:
ACCEPTED MANUSCRIPT [270] A.M. Cuer
Page 81 and 82:
ACCEPTED MANUSCRIPT Neuroscience le
Page 83 and 84:
ACCEPTED MANUSCRIPT Ferrante, N.W.
Page 85 and 86:
ACCEPTED MANUSCRIPT Meitinger, W. K
Page 87 and 88:
ACCEPTED MANUSCRIPT ACCEPTED MANUSC
Page 89:
ACCEPTED MANUSCRIPT ACCEPTED MANUSC
show all

accepted manuscript

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?